Anti-IgE Medication Lessens Pediatric Atopic Dermatitis Severity
Omalizumab, an anti-IgE medication approved to treat asthma and hives, significantly reduced children ’s atopic dermatitis severity and improved their quality of life, according to a trial in JAMA Pediatrics.
Source: JAMA - Category: General Medicine Source Type: research
More News: Asthma | Children | Dermatitis | Dermatology | General Medicine | Hives | Pediatrics | Xolair